Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
1.840
+0.030 (1.66%)
At close: Jun 12, 2026, 4:00 PM EDT
1.840
0.00 (0.00%)
After-hours: Jun 12, 2026, 4:10 PM EDT
Serina Therapeutics Employees
Serina Therapeutics had 16 employees as of December 31, 2025. The number of employees increased by 3 or 23.08% compared to the previous year.
Employees
16
Change (1Y)
3
Growth (1Y)
23.08%
Revenue / Employee
$8,125
Profits / Employee
-$1,345,063
Market Cap
27.34M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 16 | 3 | 23.08% | 16 | 0 |
| Dec 31, 2024 | 13 | 2 | 18.18% | 12 | 1 |
| Dec 31, 2023 | 11 | - | - | 9 | 2 |
| Sep 30, 2023 | 9 | - | - | 5 | 4 |
| Jun 30, 2023 | 9 | - | - | 5 | 4 |
Related Stocks
| Company Name | Employees |
|---|---|
| Pluri | 142 |
| IGC Pharma | 70 |
| Kyntra Bio | 34 |
| Palatin Technologies | 29 |
| NeuroSense Therapeutics | 17 |
| Quantum BioPharma | 17 |
| BriaCell Therapeutics | 16 |
| Tvardi Therapeutics | 12 |
SER News
- 21 days ago - Serina Therapeutics files to sell 16.45M shares of common stock for holders - TheFly
- 4 weeks ago - Serina Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates - GlobeNewsWire
- 2 months ago - Serina Therapeutics to Present at the 5th LNP Formulation & Process Development Summit - GlobeNewsWire
- 2 months ago - Serina Therapeutics announces NYSE acceptance of plan to regain compliance - TheFly
- 2 months ago - Serina Therapeutics Announces NYSE American Acceptance of Continued Listing Compliance Plan - GlobeNewsWire
- 2 months ago - Serina Therapeutics to Present at the 38th Annual Roth Conference - GlobeNewsWire
- 3 months ago - Serina Therapeutics names Greg Bailey co-chairman - TheFly
- 3 months ago - Serina Therapeutics Secures up to $30 Million in Private Placement to Advance Registrational Trial of SER-252 for Advanced Parkinson's Disease - GlobeNewsWire